Home Alerts and Recalls

Alerts and Recalls

Current diabetes related recalls and alerts, including recalls on diabetic drugs, devices, blood glucose meters, medical equipment, food, test strips, supplements and more.

Riomet Metformin Recall

Riomet Metformin Lots Recalled Due to Contamination

Riomet Metformin, used to treat type 2 diabetes in adults and children over 10, has been recalled due to contamination. See full details and lot information.
Diabetes Drug and Genital Infections

Alert: SGLT2 Inhibitors for Diabetes May Cause Serious Genital Infection

Warning that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines.
Recall Blood Pressure and Heart Medicine

Recall Expands for Various Heart and Blood Pressure Medications Nationwide

Recent recall of drugs used for high blood pressure and heart failure has been expanded to include all lots, including Amlodipine, Valsartan and Hydrochlorothiazide.

OmniPod Recall: Insulet Recalls OmniPod Insulin Management System

Recall of the OmniPod (Pod) Insulin Management System. Patients may not receive the expected insulin dose, or have insulin delivery interupted, which can cause...
Recall of Blood Pressure and Heart Failure Medicines - Valsartan

Nationwide Recall of Blood Pressure and Heart Failure Medicines

Recall of several medicines containing valsartan, which includes hypertension and heart failure drugs such as Teva, Major, Actavis and more.
Novo Nordisk NovoPen Recall

Novo Nordisk Recall: Novopen Echo Insulin Delivery Devices

Novo Nordisk is recalling certain Novopen Echo Insulin Delivery Devices due to potential health risks, including high blood sugar levels.

Drug Recall: Ranitidine Tablets, 150 mg and 300 mg Recalled Nationwide

Glenmark Pharmaceutical Inc., USA (“Glenmark”) announced on 12/19 the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to...

FDA Warns About Type 2 Diabetes Drug Canagliflozin Side Effects

FDA has strengthened it's warning for the type 2 diabetes medicine Canagliflozin, which is sold under the names Invokana and Invokamet, by adding new...
Fluoroquinolone Antibiotic Warning from FDA for Diabetics

Alert: Low Blood Sugar Warning for Certain Antibiotics, FDA Labeling Changes

FDA is strengthening the current warnings in the prescribing information that fluoroquinolone antibiotics may cause significant decreases in blood sugar (hypoglycemia) and certain mental health side effects.

Alert: Certain Type 2 Diabetes Drugs May Cause Disabling Joint Pain

The FDA is warning Type 2 Diabetics that their medication may cause them severe, disabling joint pain. Several popular diabetes drugs contain sitagliptin, saxagliptin,...
BRILINTA Recall

Nationwide Brilanta Recall by Astrazeneca Due to Acute Renal Failure Risk

Astrazeneca is recalling limited lots of of BRILINTA because bottles contain the wrong medication, which can lead to advere renal effects. Voluntary recall limited to...

Worldwide Medtronic Recall of Diabetes Infusion Sets due to Hypoglycemia Risk

Medtronic has started a worldwide recall of specific lots of infusion sets used with all models of Medtronic insulin pumps for diabetes due to hypoglycemia risk.
Walmart Produce Section - Veggie Kabob Recall

Fresh Vegetables Recalled in Multiple States and Stores, Including Walmart

Country Fresh Orlando is recalling products in several states sold as store brands that include Walmart and Publix due to risk of Listeria monocytogenes.
Researchers Testing Beta Cells

Recovering Insulin-Producing Cells in Diabetics May Be Possible

A new discovery may lead to the recovery of insulin-producing beta cells in people with type 1 diabetes. A Yale-led research team identified how insulin-producing...
Recall of Garden of Living Meal Replacements Raw Meal

Recall: Meal Replacements by Garden of Life

Recall of various Garden of Life Meal Replacement products, sold online and in retail stores, due to possible risk of Salmonella, which can cause...

FDA Warning: SGLT2 Inhibitors for Diabetes May Lead to a Serious Condition

The FDA is warning people about a new class of diabetes drugs that could result in ketoacidosis and may require hospitalization. The U.S. Food and...